MITO
Stealth BioTherapeutics Corp. ADS
MITO
MITO
Delisted
MITO was delisted on the 15th of November, 2022.
19 hedge funds and large institutions have $334K invested in Stealth BioTherapeutics Corp. ADS in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$36K | |
| 2 | +$25K | |
| 3 | +$14K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$14K |
| 5 |
HF
HRT Financial
New York
|
+$9K |
Top Sellers
| 1 | -$8.67K | |
| 2 | -$4K | |
| 3 | -$4K | |
| 4 |
Two Sigma Advisers
New York
|
-$260 |